COLGATE PALMOLIVE CO·4

Apr 3, 4:04 PM ET

BILBREY JOHN P 4

4 · COLGATE PALMOLIVE CO · Filed Apr 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Colgate (CL) Director John P. Bilbrey Receives 266 Shares

What Happened
John P. Bilbrey, a non-employee director of Colgate‑Palmolive Co. (CL), was granted 266 shares (reported as an award/acquisition, code A) on April 1, 2026. The reported grant price was $89.05 per share, for a total value of $23,687. This award reflects a deferral of his annual cash retainer into a stock unit account.

Key Details

  • Transaction date: 2026-04-01; Filing date: 2026-04-03.
  • Transaction type/code: Award/Acquisition (A).
  • Shares granted: 266 at $89.05 each; total value reported $23,687.
  • Shares owned after transaction: Not specified in the filing.
  • Footnote: Portion of annual cash retainer was deferred to a stock unit account under the Deferred Compensation Plan for Non‑Employee Directors (per filing footnote).
  • No indication this was a sale or open‑market purchase; it is a routine compensation-related award. Filing appears timely (reported two days after the transaction).

Context
Grants to non-employee directors as part of deferred compensation are common and generally reflect compensation policy rather than a direct buy or sell signal about company prospects. These awards may be settled as stock or stock units per the plan; they do not necessarily indicate an active purchase by the insider.

Insider Transaction Report

Form 4
Period: 2026-04-01
Transactions
  • Award

    Common Stock

    [F1]
    2026-04-01$89.05/sh+266$23,68737,665 total
Holdings
  • Common Stock

    (indirect: By Trust)
    4,719
Footnotes (1)
  • [F1]Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.
Signature
/s/ Kristine Hutchinson, Attorney-in-Fact|2026-04-03

Documents

1 file
  • 4
    doc4.xmlPrimary